English
Welcome, Guest
Username: Password: Remember me
Forgot your password? Forgot your username? Create an account
Support Forum
Main Forum
Experts Corner
Fibrosis and Cirrhosis
Bristol-Myers Squibb targeting fibrosis research

TOPIC: Bristol-Myers Squibb targeting fibrosis research

Bristol-Myers Squibb targeting fibrosis research 2 years 5 months ago #22788

  • Gaj
  • Gaj's Avatar
  • Offline
  • Moderator
  • Optimist :-)
  • Posts: 1436
  • Thank you received: 3084
  • Karma: 31
Bristol-Myers Squibb appear to be putting some focus on the anti-fibrosis field including investing in licencing rights for development of a promising new drug/delivery system (ND-L02-s0201) that targets HCV and Nash fibrosis.

hepatitiscnewdrugs.blogspot.com.au/2016/...signs-exclusive.html

in.reuters.com/article/us-bristol-myers-...%2F+IN+%2F+Health%29

liverlearning.aasld.org/aasld/2015/theli.../110677/[[$item.link
G3a since '78 - Dx '12 - F4 (2xHCC)
24wk Tx - PEG/Riba/Dac 2013 relapsed
24wk Tx - Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx - 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 - 22/06/17 UND
SRV12 - 27/07/17 UND
SVR24 - 26/10/17 UND
:cheer: :cheer: :cheer:
Last Edit: 2 years 5 months ago by Gaj.
The administrator has disabled public write access.
The following user(s) said Thank You: DrJames, coral, rohcvfighter, fitz
Support Forum
Main Forum
Experts Corner
Fibrosis and Cirrhosis
Bristol-Myers Squibb targeting fibrosis research
Time to create page: 0.113 seconds

Copyright © 2015-2019 FixHepC

Delivery Guarantee Privacy Terms of service
Back to Top